Larson Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.11K Buy
330
+135
+69% +$1.21K ﹤0.01% 2963
2026
Q1
$1.59K Hold
195
﹤0.01% 3023
2025
Q4
$1.31K Sell
195
-358
-65% -$2.7K ﹤0.01% 2880
2025
Q3
$4.79K Buy
553
+280
+103% +$2.18K ﹤0.01% 2367
2025
Q2
$1.72K Buy
273
+73
+37% +$483 ﹤0.01% 2467
2025
Q1
$1.28K Sell
200
-8
-4% -$66 ﹤0.01% 2311
2024
Q4
$1.67K Buy
208
+8
+4% +$77 ﹤0.01% 1923
2024
Q3
$2.53K Hold
200
﹤0.01% 1814
2024
Q2
$2.53K Hold
200
﹤0.01% 1561
2024
Q1
$956 Hold
200
﹤0.01% 1460
2023
Q4
$960 Hold
200
﹤0.01% 1475
2023
Q3
$1.45K Hold
200
﹤0.01% 1425
2023
Q2
$1.49K Sell
200
-665
-77% -$5.23K ﹤0.01% 1321
2023
Q1
$5.99K Hold
865
﹤0.01% 1046
2022
Q4
$8.89K Hold
865
﹤0.01% 894
2022
Q3
$16K Hold
865
﹤0.01% 681
2022
Q2
$44K Hold
865
0.01% 397
2022
Q1
$64K Sell
865
-6
-0.7% -$535 0.01% 340
2021
Q4
$125K Buy
871
+95
+12% +$16.3K 0.02% 244
2021
Q3
$161K Hold
776
0.03% 163
2021
Q2
$165K Buy
776
+172
+28% +$31.5K 0.04% 144
2021
Q1
$110K Buy
604
+299
+98% +$59.6K 0.03% 167
2020
Q4
$34K Buy
+305
New +$32.4K 0.01% 276
2020
Q2
Sell
-41
Closed -$1K 730
2020
Q1
$1K Buy
+41
New +$347 ﹤0.01% 497

Other funds holding NVAX

Larson Financial Group's NVAX Position: Q2 2026 in Review

Larson Financial Group increased its Novavax (NVAX) stake by 69% in Q2 2026, buying an estimated $1.21K and bringing the position to 330 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

Larson Financial Group first reported a position in NVAX in Q1 2020 and has held it in 24 quarters since. The position peaked at $165K in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Larson Financial Group held 330 shares of Novavax worth $3.11K as of Q2 2026.
  • Larson Financial Group bought 135 Novavax shares in Q2 2026, an estimated $1.21K.
  • Novavax made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2963 holding.
  • Larson Financial Group first reported a position in Novavax in Q1 2020 and has held it in 24 quarters since.
  • Larson Financial Group's Novavax position peaked at $165K in Q2 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.